These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27733562)

  • 1. Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
    Weston PS; Nicholas JM; Lehmann M; Ryan NS; Liang Y; Macpherson K; Modat M; Rossor MN; Schott JM; Ourselin S; Fox NC
    Neurology; 2016 Nov; 87(19):2050-2057. PubMed ID: 27733562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.
    Quiroz YT; Stern CE; Reiman EM; Brickhouse M; Ruiz A; Sperling RA; Lopera F; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):556-61. PubMed ID: 23134660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease.
    Weston PSJ; Poole T; Nicholas JM; Toussaint N; Simpson IJA; Modat M; Ryan NS; Liang Y; Rossor MN; Schott JM; Ourselin S; Zhang H; Fox NC
    Alzheimers Res Ther; 2020 Sep; 12(1):112. PubMed ID: 32943095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of cortical thinning in familial Alzheimer's disease.
    Knight WD; Kim LG; Douiri A; Frost C; Rossor MN; Fox NC
    Neurobiol Aging; 2011 Oct; 32(10):1765-73. PubMed ID: 20005601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
    Weston PSJ; Poole T; Ryan NS; Nair A; Liang Y; Macpherson K; Druyeh R; Malone IB; Ahsan RL; Pemberton H; Klimova J; Mead S; Blennow K; Rossor MN; Schott JM; Zetterberg H; Fox NC
    Neurology; 2017 Nov; 89(21):2167-2175. PubMed ID: 29070659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    Li X; Westman E; Thordardottir S; Ståhlbom AK; Almkvist O; Blennow K; Wahlund LO; Graff C
    J Alzheimers Dis; 2017; 56(1):327-334. PubMed ID: 27911308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
    Lee GJ; Lu PH; Medina LD; Rodriguez-Agudelo Y; Melchor S; Coppola G; Braskie MN; Hua X; Apostolova LG; Leow AD; Thompson PM; Ringman JM
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):154-62. PubMed ID: 23085935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
    Bakkour A; Morris JC; Dickerson BC
    Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70.
    Keuss SE; Coath W; Cash DM; Barnes J; Nicholas JM; Lane CA; Parker TD; Keshavan A; Buchanan SM; Wagen AZ; Storey M; Harris M; Lu K; James SN; Street R; Malone IB; Sudre CH; Thomas DL; Dickson JC; Barkhof F; Murray-Smith H; Wong A; Richards M; Fox NC; Schott JM
    J Neurol Neurosurg Psychiatry; 2024 Jul; 95(8):748-752. PubMed ID: 38199813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving brain structural changes in PSEN1 mutation carriers.
    Sala-Llonch R; Lladó A; Fortea J; Bosch B; Antonell A; Balasa M; Bargalló N; Bartrés-Faz D; Molinuevo JL; Sánchez-Valle R
    Neurobiol Aging; 2015 Mar; 36(3):1261-70. PubMed ID: 25638532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms.
    Armstrong GW; Kim LA; Vingopoulos F; Park JY; Garg I; Kasetty M; Silverman RF; Zeng R; Douglas VP; Lopera F; Baena A; Giraldo M; Norton D; Cronin-Golomb A; Arboleda-Velasquez JF; Quiroz YT; Miller JB
    JAMA Ophthalmol; 2021 Jan; 139(1):49-56. PubMed ID: 33180114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers.
    Fortea J; Sala-Llonch R; Bartrés-Faz D; Bosch B; Lladó A; Bargalló N; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2010; 22(3):909-22. PubMed ID: 20858974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease.
    Wang F; Gordon BA; Ryman DC; Ma S; Xiong C; Hassenstab J; Goate A; Fagan AM; Cairns NJ; Marcus DS; McDade E; Ringman JM; Graff-Radford NR; Ghetti B; Farlow MR; Sperling R; Salloway S; Schofield PR; Masters CL; Martins RN; Rossor MN; Jucker M; Danek A; Förster S; Lane CA; Morris JC; Benzinger TL; Bateman RJ;
    Neurology; 2015 Sep; 85(9):790-8. PubMed ID: 26245925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.
    Quiroz YT; Budson AE; Celone K; Ruiz A; Newmark R; Castrillón G; Lopera F; Stern CE
    Ann Neurol; 2010 Dec; 68(6):865-75. PubMed ID: 21194156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer's Disease.
    Zhao T; Quan M; Jia J
    J Alzheimers Dis; 2020; 73(4):1435-1444. PubMed ID: 31929167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.